Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (MRK), sold 76,252 shares at $85.01 ($6.5M) on 2019-08-08, disclosed to the SEC on 2019-08-12.
Open-market sale of $6.5M MRK by EVP&Pres, Merck Animal Heallth. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.01 | 31,699 | $2.7M | 41.6% |
| 2 | $85.01 | 31,699 | $2.7M | 41.6% |
| 3 | $85.09 | 6,427 | $547K | 8.4% |
| 4 | $85.09 | 6,427 | $547K | 8.4% |
| Total | $85.02 avg | 76,252 | $6.5M | 100% |
| Filing → |
| MRK | SELL | 2026-02-06 | $4.6M | — | Filing → |
| MRK | SELL | 2023-11-09 | $9.2M | — | Filing → |
| MRK | SELL | 2023-05-02 | $25.1M | — | Filing → |